organophosphonates has been researched along with thromboxane a2 in 1 studies
| Studies (organophosphonates) | Trials (organophosphonates) | Recent Studies (post-2010) (organophosphonates) | Studies (thromboxane a2) | Trials (thromboxane a2) | Recent Studies (post-2010) (thromboxane a2) |
|---|---|---|---|---|---|
| 9,968 | 880 | 3,596 | 5,617 | 224 | 429 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akiba, S; Hashizume, T; Hayama, M; Kageura, T; Kitatani, K; Sato, T | 1 |
1 other study(ies) available for organophosphonates and thromboxane a2
| Article | Year |
|---|---|
Ceramide enhances susceptibility of membrane phospholipids to phospholipase A2 through modification of lipid organization in platelet membranes.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Cell Membrane; Ceramides; Cytosol; Enzyme Activation; Enzyme Inhibitors; In Vitro Techniques; Lysophosphatidylcholines; Organophosphonates; Phospholipases A; Phospholipases A2; Phospholipids; Rabbits; Signal Transduction; Thromboxane A2 | 1999 |